Filter
471
Text search:
PrEP
Featured
70
102
Language
Document type
164
122
82
31
21
18
8
7
6
4
3
1
1
Countries / Regions
25
16
14
14
9
9
6
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
154
34
20
7
7
4
1
Toolboxes
222
19
13
11
10
9
9
7
7
7
5
4
3
3
3
2
2
2
2
1
1
1
Informations sur le VIH/SIDA
Private sector engagement opens pathways for a game-changing US$2 billion investment opportunity in the fight against HIV, tuberculosis and malaria.
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex B
Mathematical modelling of lenacapavir: landscaping review on impact and cost–effectiveness
recommended
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex E
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex G Abstract
Esc Anna Nery 2024;28:e20240093
Consumer Info Sheet
Policy information sheet
National Policy
Handout presentations in PDF for illustrating lectures
Accessed May 2014
Handout presentations in PDF for illustrating lectures
Accessed May 2014
Accessed 24 June 2014
Kenya: Guidelines on use of antiretroviral drugs for treating and preventing HIV infection
recommended
2018 Edition
These guidelines – an update to the World Health Organization’s 2015 publication Consolidated strategic information guidelines – present a set of essential aggregate indicators and guidance on choosing, collecting and systematically analysing strategic information to manage and monitor the nat
...
